MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41392-026-02816-z

Медицинская библиотека · Signal transduction and targeted therapy · 2026

Zinc accumulation in macrophages exacerbates metabolic dysfunction-associated steatotic liver disease progression.

Zhou Jiahui, Wang Xinhui, Liu Wen-Yue, Yu Yingying, Wang Shujie, Yao Ziqin, Song Zijun, Shi Wanting, Zheng Wanru, Xie Enjun, Yang Yi, Sun Shumin, Wu Xiaotian, Phatthalung Pinanong Na, Lian Li-You, Min Junxia, Wang Fudi

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 1 billion people globally, yet the role of trace elements in its progression remains poorly defined. Here, we identify "macrophage zinc trapping" (i.e., selective zinc accumulation in hepatic macrophages despite systemic zinc depletion) as a critical driver of MASLD. In a cohort of 1069 individuals with MASLD, we found that serum zinc levels were inversely correlated with the disease severity. In a mouse model of MASLD, the hepatic macrophages are marked by zinc accumulation. Macrophage-specific depletion of the zinc exporter Slc30a1 in mice recapitulates human MASLD pathology. In macrophage-specific Slc30a1-deficient mice, trapped zinc activates the Ire1α-Xbp1s pathway, which on the one hand stimulates IL-1β secretion to alter hepatocyte lipid metabolism via IL-1β signaling, and on the other hand enhances direct lipid transfer from macrophages to hepatocytes, thereby synergistically exacerbating steatosis. Notably, treatment with Ire1α inhibitors (4μ8C and STF-083010) or IL-1β blockade (clinically approved anti-IL-1β antibodies) reverse established steatosis, inflammation, and fibrosis in preclinical mouse models. This work redefines the role of zinc in MASLD, shifting the paradigm from systemic deficiency to cell-specific sequestration. It reveals that zinc accumulation in macrophages exacerbates hepatocyte lipid accumulation through both fatty acid transflux and inflammation-driven metabolic reprogramming, uncovering novel therapeutic targets and a clinically actionable biomarker.

Для цитирования: Zhou Jiahui, Wang Xinhui, Liu Wen-Yue, Yu Yingying, Wang Shujie, Yao Ziqin, Song Zijun, Shi Wanting, Zheng Wanru, Xie Enjun, Yang Yi, Sun Shumin, Wu Xiaotian, Phatthalung Pinanong Na, Lian Li-You, Min Junxia, Wang Fudi. Zinc accumulation in macrophages exacerbates metabolic dysfunction-associated steatotic liver disease progression.. Signal transduction and targeted therapy. 2026. DOI: 10.1038/s41392-026-02816-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.